ClinicalTrials.gg
AvailableNCT05608486CO-STARUpdated Apr 16, 2024

Continuation Protocol for Study Using Negative Pressure to Reduce Apnea Trial

An expanded access record providing aerSleep II in Obstructive Sleep Apnea and Sleep Apnea, sponsored by Sommetrics, Inc.. Available. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-16.

Sponsored by Sommetrics, Inc. · Expanded access

Study type
Expanded access
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to allow continued access to the aerSleep II System for subjects that have completed the SOM-029 study until the device is commercially available.

Read the detailed description

This is a multi-center uncontrolled continuation study designed to mimic real-world use of the aerSleep II System for subjects that have completed the SOM-029 protocol.

Subjects will use the aerSleep II nightly at a fixed pressure of -30 cmH2O. Internal electronics will record various measures of how the device is being used and how it performs.

Subjects will have a video visit with the study site approximately every 30 days, and, if the Investigator feels it is warranted or at the subject's discretion, an in-person visit at the study site will occur approximately every 90 days. During these visits, subjects will be queried for adverse events and asked to complete simple subjective evaluations of their experiences. The Investigator will complete a scale rating how well the device is managing the subject's obstructive sleep apnea (OSA).

Data collected from the device will be retrieved approximately every 90 days to monitor vacuum delivery and subject compliance.

02

Conditions studied

  • Obstructive Sleep Apnea
  • Sleep Apnea
03

In context

Sleep Apnea, Obstructive

2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Sommetrics, Inc. is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. The subject completed study SOM-029 (SUPRA).
  2. The Investigator feels that the subject experienced sufficient benefit from aerSleep II to justify its further use.
  3. In the Investigator's judgement, the subject will be able to understand and comply with all study procedures.

Exclusion criteria

Exclusion Criteria:

  1. The Investigator feels that, for any reason, the subject's participation may not be in his or her best interest.
  2. Any condition or circumstance that in the opinion of the Investigator is likely to prevent accurate data collection or bias the results.
  3. The subject is pregnant or plans to become pregnant during the course of the study.
05

Access details

Study type
Expanded access

Available treatment

  • DeviceaerSleep II

    The aerSleep® II System includes a soft silicone collar, which is placed on the anterior neck. Integrated with the collar is a vacuum pump module (VPM), which cordlessly powers the generation of negative pressure within the collar's cavity. This negative pressure pulls the underlying tissues forward, maintaining airway patency.

    Also known as: Continuous Negative External Pressure (cNEP)

06

Where to request access

No study locations are listed for this record.

07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT05608486
Lead sponsor
Sommetrics, Inc.
Responsible party
Sponsor
First posted
Nov 8, 2022
Last update
Apr 16, 2024

Study contacts

Eric Koehler
Contact
ekoehler@sommetrics.com
760-295-5620
Richard Rose, M.D.
Contact
rrose@sommetrics.com
Kingman P. Strohl, M.D.
principal investigator · Case Western Reserve University School of Medicine
View the source record on ClinicalTrials.gov ↗

Requesting access

Expanded access is arranged between your doctor and the company. Ask your care team to contact the provider listed on this record.

Contact the provider

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion